Kevin O’Neill is President & CEO of GE UK in addition to his role as President & CEO of GE Healthcare’s global Pharmaceutical Diagnostics business which is a leading global provider of contrast and nuclear medicine agents that enable clinicians to perform essential imaging procedures, as well as providing molecular tools for therapy selection and treatment monitoring.
Prior to this, Kevin was the Chief Financial Officer of GE Healthcare Life Sciences, a $4.5 billion molecular medicine business providing a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing.
Kevin has over 20 years’ experience with GE, beginning in the Energy services business in the UK, and USA, followed by a series of CFO roles in GE Healthcare including in the Life Sciences Supply Chain, Western Europe and the Pharmaceutical Diagnostics business.
Prior to joining GE, Kevin was Financial Controller for Eurostar, the European high-speed train operator. He earned his MBA from City University, London in 1999, and is a Fellow of the Chartered Institute of Management Accountants.